Ishares Nasdaq Biotechnology Index (IBB) has been on a tear in the last year, outperforming the NASDAQ and S&P 500 by multiples greater than 3x and 6x, respectively. This rapid appreciation has spurted chatter of a bubble forming in the biotech sector. Even US leaders have expressed a difference of opinion. Yellen, for example, stated back in July 2014 that the biotech industry […]
PhotoInvestors following the ups and downs of the stock markets at a brokerage house in Beijing.Credit Gilles Sabrie for The New York TimesThe symptoms, medical experts say, appear suddenly and often linger for months: insomnia, irritability, depression and an obsession with tracking stock prices.Amid the recent turmoil in China’s stock markets, as values plummeted from all-time highs, doctors have reported […]
Markets are rebounding today after a horrible beginning to the week. Looking in the biotech sector, I’m seeing a sea of green with very few blemishes. I’ve also been able to dig out a few great opportunities in the sector. Here they are…Gilead Sciences Is Likely To See Long Run GainsGilead Sciences, Inc. (NASDAQ: GILD)I’ve talked about Gilead Sciences quite […]
Google FinanceShares of Aerie Pharmaceuticals erased more than two-thirds of their value in a few minutes late on Thursday.The stock closed nearly 2% higher at $35.39 per share, giving the company a market value of $850 million. Then shortly after the end of trading, the company announced that Rhopressa, an experimental eye drop, failed a late-stage test.In after-hours trading, shares crashed by more […]
GILD Stock Continues Recovery From Monday’s FallGilead Sciences, Inc. (NASDAQ: GILD)GILD stocks fell hard Monday; losing more than two percent as the company issued a warning to doctors treating their patients with Sovaldi in combination with antiarrhythmics. However, the slide stopped and the stock started to move in the positive direction. Today, it seems as though the stock is staying […]
Small Cap Health Care & Biotech Leading The Way In 2015 Thus FarHealth Care/Biotech Names Still DominatingThe average stock in the Russell 3,000 (which makes up roughly 98% of US-listed stocks) is now up 1.68% in 2015. Below we have calculated the average year-to-date performance of stocks by sector. As shown, Health Care (XLV) (IBB) stocks are up by far […]
The medicine man, for the win.My current biotech holdings consist of NDRM, GILD, AMGN (big pharma), JAZZ, ICPT, SGEN and I own a few hospital names like LPNT and HCA. I am a man of many hats. But I will tell you, this sector isn’t done going higher.Just the other day, this industry was down in the dirt, Hybrid score […]
Markets ended in the red zone for the second-consecutive day on Monday as oil price slide continued to dent investor sentiment. Moreover, dismal earnings outlook also dragged down benchmarks yesterday. However, some merger and acquisition news limited day’s losses. More than 75% of the Dow components ended in negative territory on Monday.For a look at the issues currently facing the […]
Mark Schoenebaum, the biotech and pharmaceutical analyst at Evercore ISI, asked ;the Twittersphere for their favorite drug stocks going into next year.
What’s your favorite stock for 2015 in biotech or Pharma?
– Mark Schoenebaum (@MarkSchoenebaum) December 12, 2014What was the top pick? A 21-way tie for first place. All 21 companies got a single vote.I kid you not. As I’m writing […]
Kyle Anderson: When researching the best biotech stocks to buy, investors often look for companies that will cure terrible, chronic diseases.Until recently, these biotech stocks have been elusive.Have you ever wondered how billionaires continue to get RICHER, while the rest of the world is struggling?“I study billionaires for a living. To be more specific, I study how these investors generate such huge and consistent […]